Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$690,430
+$197,482 QoQ
Shares Held
5,373
+31.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,428
of 3,769 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stokes Capital Advisors, LLC holds $39,481,428 across 8 Drug Manufacturers - General names. MRK ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,779 | $11,729,226 | |
| 2 | JNJ |
Johnson & Johnson
|
43,686 | $11,094,933 | |
| 3 | ABBV |
AbbVie Inc.
|
37,456 | $9,425,427 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
35,370 | $4,468,645 | |
| 5 | AMGN |
Amgen Inc
|
3,061 | $1,108,449 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
5,373 | $690,430 | |
| 7 | PFE |
Pfizer Inc
|
22,925 | $552,034 | |
| 8 | NVO |
Novo Nordisk A S
|
8,600 | $412,284 |
All Filings in MRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $690,430 | 5,373 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $492,948 | 4,098 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $237,887 | 2,260 | Shares | Sole | 2026-01-12 | |
| 2024-12-31 | $4,409,351 | 44,324 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $4,855,030 | 42,753 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $4,853,702 | 39,206 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $4,334,029 | 32,846 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,448,956 | 31,636 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $3,219,452 | 31,272 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,611,476 | 31,298 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $3,478,421 | 32,695 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,705,508 | 33,398 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $3,124,003 | 36,275 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,557,861 | 49,993 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $4,234,682 | 51,611 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,728,306 | 48,647 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,724,855 | 49,592 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $3,917,352 | 50,371 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,739,869 | 48,513 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $3,644,842 | 44,558 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $3,392,573 | 40,899 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,928,488 | 37,870 | Shares | Sole | 2020-07-15 | |
| No filing history on record for this holder in this stock. | ||||||